Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

Clinical trial NCT06343779 · COMPLETED

Trial details

NCT number: NCT06343779
Sponsor: Pharvaris Netherlands B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema Hereditary Angioedema Type I Hereditary Angioedema Type II Hereditary Angioedema Types I and II Hereditary Angioedema Attack Hereditary Angioedema With C1 Esterase Inhibitor Deficiency Hereditary Angioedema - Type 1 Hereditary Angioedema - Type 2 C1 Esterase Inhibitor [C1-INH] Deficiency C1 Esterase Inhibitor Deficiency C1 Esterase Inhibitor, Deficiency of C1 Inhibitor Deficiency

Start date: 2024-02-26
Primary completion: 2025-10-17
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.